Ibnsina Pharma reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EGP 6,843.37 million compared to EGP 5,332.8 million a year ago. Net income was EGP 72.55 million compared to EGP 59.38 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 EGP | 0.00% | -8.20% | -28.66% |
03/03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
05/02 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.66% | 48.19M | |
-31.48% | 15.83B | |
-22.25% | 12.31B | |
-25.47% | 6.59B | |
+12.51% | 6.45B | |
-9.71% | 5.94B | |
-0.15% | 4.66B | |
+62.00% | 4.59B | |
-4.98% | 3.96B | |
-8.76% | 3.55B |
- Stock Market
- Equities
- ISPH Stock
- News Ibnsina Pharma
- Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2023